| 2001 |
Tbx1 haploinsufficiency is sufficient to cause aortic arch defects (fourth pharyngeal arch artery defects) in mice in a gene dosage-dependent manner; homozygous mutation severely disrupts the pharyngeal arch artery system, establishing Tbx1 as the haploinsufficient gene within the DiGeorge chromosomal region. |
Chromosome engineering (targeted heterozygous and homozygous deletion), P1 artificial chromosome transgenesis, genetic rescue in mouse |
Nature |
High |
11242049
|
| 2001 |
Tbx1 expression in pharyngeal arch development is regulated downstream of Sonic hedgehog (Shh) signaling; Shh is sufficient to induce Tbx1 expression when misexpressed in chick embryos, and Tbx1 expression is lost in Shh-null mouse embryos. |
In situ hybridization in Shh-null mice, Shh misexpression in chick embryos |
Developmental biology |
High |
11412027
|
| 2002 |
Tbx1 deficiency causes a cell-autonomous function in the growth of the pharyngeal apparatus and a cell non-autonomous function in growth and remodeling of pharyngeal arch arteries, as shown by Tbx1-lacZ reporter allele analysis. |
Tbx1-lacZ reporter allele, phenotype/expression comparison in Tbx1 null mice |
Human molecular genetics |
Medium |
11971873
|
| 2002 |
Tbx1 genetically interacts with Fgf8: Fgf8 expression is abolished in the pharyngeal endoderm of Tbx1-null mutants, and double heterozygous Tbx1+/-;Fgf8+/- mice show significantly higher penetrance of aortic arch artery defects than either single heterozygote, establishing a genetic link between Tbx1 and FGF signaling. |
In situ hybridization, genetic intercross of Tbx1 and Fgf8 mutant mice |
Development (Cambridge, England) |
High |
12223416
|
| 2003 |
TBX1 is regulated by tissue-specific forkhead (Fox) transcription factors (Foxa2, Foxc1, Foxc2) through a single cis-element upstream of Tbx1 that is essential for its transcription in pharyngeal endoderm and head mesenchyme; this regulatory region is also responsive to Shh signaling in vivo. |
Enhancer reporter assays, transgenic mice, Shh loss-of-function, ChIP/binding assays for Fox proteins |
Genes & development |
High |
12533514
|
| 2000 |
TBX1 protein binds a palindromic T-box oligonucleotide as a dimer in vitro but has no effect on transcription of a chimeric reporter plasmid in the assay used, in contrast to TBX2 (repressor) and Xbra/T (activator), demonstrating that TBX1 DNA binding does not inherently drive strong transcriptional activation or repression through T-box elements. |
In vitro DNA binding assays, transcriptional reporter assays |
Gene |
Medium |
11111039
|
| 2004 |
Tbx1 has a dual role in cardiac outflow tract morphogenesis: (1) it supports cell proliferation in the secondary heart field, and (2) it is required in Nkx2.5-expressing cells for formation of the aorto-pulmonary septum. Fgf10 is identified as a direct transcriptional target of Tbx1 in vitro. |
Tissue-specific deletion using Cre/loxP, cell proliferation assays, in vitro transcription activation assay for Fgf10 |
Development (Cambridge, England) |
High |
15175244
|
| 2004 |
Tbx1 is required in pharyngeal mesoderm for branchiomeric myogenesis: in its absence, myogenic determination genes Myf5 and MyoD fail to be normally activated in pharyngeal mesoderm, while Capsulin/MyoR-expressing unspecified precursor cells persist. |
Tbx1 null mouse analysis, in situ hybridization for myogenic markers |
Human molecular genetics |
High |
15385444
|
| 2004 |
Tbx1 regulates FGF signaling in an autoregulatory loop in the anterior heart field: a Fox-binding site upstream of Tbx1 interacts with Foxa2 in pharyngeal mesoderm, and Tbx1 itself regulates an Fgf8 enhancer in the cardiac outflow tract; Tbx1 gain-of-function expands Fgf10-marked outflow tract myocardium. |
Tbx1 allelic series (hypomorphic mice), enhancer reporter assays, in vivo gain-of-function transgenic mice |
Development (Cambridge, England) |
High |
15469978
|
| 2005 |
Tbx1 function in fourth pharyngeal arch artery development is cell non-autonomous and requires expression specifically in pharyngeal epithelia; Tbx1 is also expressed in endothelial cell precursors of pharyngeal arch arteries. |
Cell fate mapping, tissue-specific Cre-mediated deletion using six Cre lines |
Development (Cambridge, England) |
High |
16284121
|
| 2005 |
Retinoic acid (RA) down-regulates Tbx1 expression in vivo and in vitro in a dose-dependent manner, independently of the Shh/Foxa2 regulatory pathway, placing RA as an upstream repressor of Tbx1. |
Vitamin A-deficient quail model, RA bead grafts in chick, real-time PCR of RA-treated P19 cells, protein synthesis inhibitor experiments |
Developmental dynamics |
High |
15736167
|
| 2005 |
Tbx1 is required throughout pharyngeal segmentation for regulation of endoderm expansion, as defined by timed Cre-mediated deletion revealing distinct time windows for each pharyngeal derivative. |
Timed Cre-mediated deletion, cell fate mapping in mouse |
Development (Cambridge, England) |
High |
16141220
|
| 2006 |
Mesodermal expression of Tbx1 is both necessary and sufficient for pharyngeal arch and cardiac outflow tract development; Tbx1 in mesoderm is required to sustain cell proliferation; restoration of mesodermal Tbx1 in null background rescues most pharyngeal and cardiovascular defects. |
Mesoderm-specific Cre deletion and transgenic rescue in mouse |
Development (Cambridge, England) |
High |
16914493
|
| 2006 |
Tbx1 expression in pharyngeal endoderm is required for patterning and development of the pharyngeal apparatus and its derivatives; loss of Tbx1 in pharyngeal endoderm blocks pharyngeal pouch outgrowth. |
Cre/loxP conditional knockout using Foxg1-Cre for pharyngeal endoderm-specific ablation in mouse |
Development (Cambridge, England) |
High |
16452092
|
| 2006 |
Tbx1 haploinsufficiency causes prepulse inhibition (PPI) deficits, a schizophrenia endophenotype; single-gene Tbx1+/- mice are sufficient to produce this behavioral phenotype, linking Tbx1 to psychiatric features of 22q11DS. |
Mouse behavioral assays (PPI), defined mouse mutant panel with overlapping deletions, human family mutation analysis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16684884
|
| 2006 |
Tbx1 and Crkl (22q11 genes) interact in a dose-dependent manner to control pharyngeal segmentation and patterning along the anteroposterior axis; compound heterozygosity causes increased penetrance of DiGeorge-like phenotype; local regulation of retinoic acid metabolism is disrupted; partial rescue achieved by genetically reducing RA production. |
Genetic intercross of Tbx1 and Crkl mutant mice, genetic reduction of RA (Raldh2 heterozygosity), phenotypic analysis |
Developmental cell |
High |
16399080
|
| 2006 |
Tbx1 is regulated in the secondary heart field by forkhead (Fox) proteins through two evolutionarily conserved Fox-binding sites; SHF-derived Tbx1-expressing cells (fate-mapped by the Tbx1 enhancer) contribute to right ventricular infundibulum, pulmonary trunk, and pulmonary valves. |
Enhancer reporter assays with conserved Fox binding site mutations, cell fate analysis using Tbx1 enhancer-driven Cre in mouse |
Developmental dynamics |
High |
16444712
|
| 2006 |
Cyp26a1, Cyp26b1, and Cyp26c1 (retinoic acid-degrading enzymes) are down-regulated in Tbx1 null pharyngeal tissues, placing Cyp26 genes downstream of Tbx1; inhibition of Cyp26 enzyme function in chick phenocopies DiGeorge syndrome, linking Tbx1-dependent RA catabolism to pharyngeal development. |
Real-time PCR and in situ hybridization in Tbx1 null mice, pharmacological Cyp26 inhibition (R115866) in chick embryos |
Human molecular genetics |
High |
17047027
|
| 2006 |
Tbx1 binds to a Pitx2 cardiac enhancer (containing a T-half site near an Nkx2.5-binding site) in vitro and activates it synergistically with Nkx2.5; Tbx1 co-expressed with Pitx2 in secondary heart field; Tbx1+/-;Pitx2+/- double heterozygotes die perinatally with cardiac defects. |
In vitro binding and transcriptional assays, genetic intercross, in situ hybridization |
Development (Cambridge, England) |
High |
16556915
|
| 2007 |
Fate mapping using Tbx1Cre knock-in reveals that Tbx1-expressing cell descendants constitute a mesodermal population surrounding the primitive pharynx that populates most of the outflow tract (excluding the anterior portion) including both myocardial and endocardial layers, suggesting a common origin. |
Tbx1Cre knock-in allele, reporter-based fate mapping, 3D image reconstruction in mouse |
Genesis |
High |
17610275
|
| 2008 |
Tbx1 controls cardiac neural crest cell migration to caudal pharyngeal arch arteries non-autonomously by regulating Gbx2 expression in the pharyngeal surface ectoderm; Gbx2 downstream of Tbx1 triggers directional cues to cardiac NCCs; Slit/Robo signaling components are affected in Gbx2 and Tbx1 mutants. |
Genetic approaches (conditional deletion, ectodermal Cre), NCC migration analysis, molecular marker analysis in mouse |
Development (Cambridge, England) |
High |
19700621
|
| 2008 |
Tbx1 is required for the development of subpulmonary myocardium at the base of the pulmonary trunk; Semaphorin3c is identified as a Tbx1-dependent gene expressed in subpulmonary myocardium; loss of Tbx1 causes anomalous coronary artery patterning. |
Genetic crosses using transgene markers of second heart field myocardium and coronary endothelial cells, gene expression analysis in Tbx1 mutant mice |
Circulation research |
High |
18583714
|
| 2008 |
Tbx1 and Brn4 cooperate in the periotic mesenchyme for cochlear formation; Brn4 expression is reduced in Tbx1 null mutants; Brn4-;Tbx1+/- double mutants show more severe cochlear defects (Mondini dysplasia) than either single mutant. |
Generation and analysis of double-mutant mice (Brn4-;Tbx1+/-), inner ear phenotyping |
Journal of the Association for Research in Otolaryngology |
Medium |
18231833
|
| 2009 |
Tbx1 is expressed in multipotent cardiac progenitor cells (CPCs) of the second heart field; it stimulates CPC proliferation and inhibits differentiation; Tbx1 binds serum response factor (SRF) and negatively regulates its levels; loss of Tbx1 causes premature differentiation while gain prevents differentiation in vivo. |
Clonal analysis, loss- and gain-of-function models in vivo and in vitro, Co-immunoprecipitation (Tbx1-SRF binding) |
Circulation research |
High |
19745164
|
| 2009 |
Tbx1 regulates the BMP-Smad1 signaling pathway in a transcription-independent manner: Tbx1 physically binds Smad1 (Co-IP), suppresses Bmp4/Smad1 signaling, and interferes with Smad1-Smad4 binding. A TBX1 mutation that abolishes transactivation does not affect Smad1 binding; a disease-associated TBX1 mutation that does not prevent transactivation blocks TBX1-SMAD1 interaction. Tbx1 gain-of-function in transgenic mice generates phenotypes similar to loss of a Bmp receptor. |
Co-immunoprecipitation, transactivation assays with separation-of-function mutants, transgenic mice with Tbx1 gain-of-function and Smad1 transgenic rescue |
PloS one |
High |
19557177
|
| 2009 |
Tbx1 requires biallelic expression in pharyngeal ectoderm together with Chd7 for normal fourth pharyngeal arch artery development; Tbx1+/-;Chd7+/- double heterozygotes show synergistic interaction affecting fourth PAA, thymus, and ear morphogenesis; neural crest-specific Chd7 rescue did not restore PAA morphogenesis. |
Double heterozygous mouse crosses, tissue-specific neural crest Chd7 rescue experiments, arch artery phenotyping |
The Journal of clinical investigation |
High |
19855134
|
| 2009 |
Tbx1 controls pharyngeal pouch morphogenesis in zebrafish through mesodermal wnt11r and fgf8a: Tbx1 promotes pouch-forming endoderm morphogenesis through these mesodermal signals; compound loss of wnt11r and fgf8a phenocopies tbx1 mutant pouch defects; mesoderm-specific restoration of Wnt11r and Fgf8a rescues tbx1 mutant pouches; Fgf8a acts as a Wnt11r-dependent guidance cue for migrating pouch cells. |
Zebrafish mutant/transgenic rescue experiments, time-lapse imaging, compound loss-of-function |
Development (Cambridge, England) |
High |
25142463
|
| 2010 |
Tbx1 activates Vegfr3 transcription in endothelial cells by binding to an enhancer element in the Vegfr3 gene; conditional deletion of Tbx1 in endothelial cells causes widespread lymphangiogenesis defects in mice; Tbx1 is required for growth and maintenance, but not differentiation, of lymphatic endothelial cells. |
Molecular (enhancer binding assays), conditional endothelial-specific Tbx1 knockout, lymphatic vessel phenotyping |
The Journal of cell biology |
High |
20439995
|
| 2010 |
Ash2l (component of a histone methyltransferase complex) physically interacts with Tbx1 in both yeast and mammalian cells and acts as a transcriptional co-activator in luciferase reporter assays; Tbx1 and Ash2l have overlapping expression during development. |
Yeast two-hybrid screen, Co-immunoprecipitation in mammalian cells, luciferase reporter assays, Ash2l knockout mouse |
Experimental biology and medicine |
Medium |
20463296
|
| 2010 |
Tbx1 negatively regulates Pitx2 transcriptional activity; Tbx1 physically interacts with the PITX2 C-terminus and represses PITX2 activation of p21, LEF-1, and Pitx2c promoters; this mechanism controls cell proliferation in dental epithelium. Tbx1(-/+)/Pitx2(-/+) double heterozygous mice show extra premolar-like teeth, confirming genetic interaction. |
Co-immunoprecipitation, luciferase reporter assays, chromatin immunoprecipitation, conditional knockout mice, double heterozygous mouse analysis |
Developmental biology |
High |
20816801
|
| 2011 |
Six1 and Eya1 genetically interact with Tbx1 in a Tbx1-Six1/Eya1-Fgf8 pathway controlling cardiovascular and craniofacial morphogenesis; Fgf8 is a direct downstream effector of Six1 and Eya1; Six1/Eya1 double mutants recapitulate del22q11 features. |
Mouse genetic intercrosses, gene expression analysis, direct target identification |
The Journal of clinical investigation |
High |
21364285
|
| 2011 |
Tbx1 downstream pathway in the second heart field includes Isl1 (downregulated in Tbx1 null); Tbx1 positively regulates SHF cell proliferation and negatively regulates differentiation; pan-mesodermal ablation of Tbx1 causes cell-autonomous gene expression changes; opposite changes occur in TBX1 gain-of-function mutants. |
Gene expression profiling, pan-mesodermal Tbx1 ablation (T-Cre), TBX1 gain-of-function transgenic mice |
Developmental biology |
High |
18328475
|
| 2011 |
Ripply3 suppresses Tbx1 transcriptional activation activity in luciferase assays; Ripply3 represses Tbx1-induced Pax9 expression; Ripply3-deficient mice have pharyngeal defects and upregulated Pax9, consistent with relief of Tbx1 repression. |
Luciferase reporter assays, Ripply3 knockout mouse, in situ hybridization for Pax9 |
Development (Cambridge, England) |
High |
21177346
|
| 2011 |
Tbx1 loss reduces Hes1 expression in Tbx1-expressing lineages; Hes1 (Notch signaling effector) mutant mice have 22q11DS-like defects; conditional Hes1 inactivation in pharyngeal ectoderm (like Tbx1) causes thymus and PAA defects, placing Hes1 downstream of Tbx1. |
FACS-Gal sorting of Tbx1-expressing cells, expression profiling, Hes1 conditional knockout in pharyngeal ectoderm |
Developmental biology |
High |
20122914
|
| 2012 |
The histone acetyltransferase MOZ complex occupies the Tbx1 locus, promotes Tbx1 expression and histone 3 lysine 9 acetylation; Moz null mice phenocopy DiGeorge syndrome; Moz and Tbx1 genetically interact (Moz+/-;Tbx1+/- mice show enhanced phenotype); a Tbx1 transgene rescues heart phenotype in Moz mutants. |
ChIP for MOZ at the Tbx1 locus, MOZ knockout and heterozygous mouse analysis, Tbx1 transgenic rescue |
Developmental cell |
High |
22921202
|
| 2012 |
Tbx1 directly regulates Fgf10 expression in anterior second heart field cells through a 1.7-kb intronic region; Tbx1 ChIP binding at this region is demonstrated in vivo. |
Transgenic reporter assay of Fgf10 1.7-kb intronic element, ChIP for Tbx1 at Fgf10 locus |
Proceedings of the National Academy of Sciences of the United States of America |
High |
23093675
|
| 2012 |
Tbx1 is a negative modulator of Mef2c: Mef2c expression is negatively correlated with Tbx1 dosage in the second heart field; Tbx1 occupies conserved regulatory regions of the Mef2c locus (ChIP); Tbx1 also interferes with the Gata4→Mef2c regulatory pathway. |
Microarray transcriptome analysis across Tbx1 allelic series, in situ hybridization, Tbx1 gain-of-function analysis, ChIP |
Human molecular genetics |
High |
22367967
|
| 2012 |
Tbx1 acts upstream of Smad7 in pharyngeal arch artery remodeling: Smad7 expression is regulated by Tbx1, and Tbx1;Smad7 compound haploinsufficiency impairs vascular smooth muscle cell coverage and fibronectin deposition in the fourth arch artery; Tbx1Cre-driven conditional Smad7 reconstitution shows the interaction is cell autonomous. |
Tbx1/Smad7 double heterozygous mouse crosses, conditional Smad7 reconstitution with Tbx1Cre, vascular phenotyping |
Circulation research |
High |
23011393
|
| 2013 |
Tbx1 regulates brain angiogenesis in a cell-autonomous manner in endothelial cells; TBX1 regulates DLL4 and VEGFR3 genes in brain endothelial cells; EC-specific Tbx1 conditional mutants have brain vessel hyperplasia, enhanced sprouting, and network disorganization; a Notch1 agonist partially rescues microtubule hyperbranching caused by TBX1 knockdown, placing TBX1 upstream of DLL4/Notch1-VEGFR3 axis. |
EC-specific conditional Tbx1 knockout, 3D EC-matrigel culture system, Notch1 agonist rescue experiment |
Human molecular genetics |
High |
23945394
|
| 2013 |
In zebrafish, tbx1 regulates heart looping and cardiomyocyte differentiation through wnt11r (non-canonical Wnt) and alcama (activated leukocyte cell adhesion molecule a); wnt11r and alcama are downregulated in tbx1 null; ectopic expression of wnt11r or alcama partially rescues tbx1 mutant heart looping defects. |
Zebrafish tbx1 null analysis, gene expression studies, morpholino knockdown, mRNA rescue injection |
PloS one |
High |
23533583
|
| 2014 |
Tbx1 is required for inflow as well as outflow tract morphogenesis by regulating segregation and deployment of posterior second heart field progenitor cells; in Tbx1 null embryos, OFT progenitor cells fail to segregate from the posterior SHF progenitor pool; addition of SHF cells to the venous pole is also impaired, causing atrioventricular septal defects. |
Transcriptome analysis, genetic tracing with Tbx1Cre and SHF markers, fluorescent dye labeling in mouse embryos |
Circulation research |
High |
25190705
|
| 2014 |
TBX1 regulates epithelial polarity and dynamic basal filopodia in second heart field cells; Tbx1 null SHF cells show increased circularity, reduced basolateral membrane domain, impaired filopodial activity, and elevated aPKCζ levels; aPKCζ activation phenocopies Tbx1 null proliferative and differentiation defects. |
Immunofluorescence, live imaging, embryo culture, aPKCζ activation in embryo culture |
Development (Cambridge, England) |
High |
25371366
|
| 2014 |
Pax9 is downstream of Tbx1 in pharyngeal endoderm; Tbx1/Pax9 double heterozygous mice have significantly increased incidence of interrupted aortic arch; using Pax9Cre, the site of interaction is defined as the pharyngeal endoderm. |
Tbx1/Pax9 double heterozygous mouse crosses, Pax9Cre conditional allele, transcriptome analysis |
Development (Cambridge, England) |
High |
31444215
|
| 2015 |
TBX1 interacts with PITX2 to negatively regulate PITX2 transcriptional activity; miR-96-5p represses TBX1 expression and TBX1 represses miR-96, forming a regulatory loop; TBX1 regulates dental progenitor cell proliferation through miR-96-5p and PITX2; human TBX1 disease mutations show functional differences in transcriptional regulation of miR-96 and co-regulation of PITX2. |
Conditional Tbx1 knockout/overexpression in dental epithelium, lineage tracing, luciferase assays, miR-96 manipulation, Co-IP of TBX1 and PITX2 |
Human molecular genetics |
High |
25556186
|
| 2019 |
Tbx1 is required to maintain integrity of extracellular matrix (ECM)-integrin-focal adhesion (FA) signaling in the second heart field; loss of TBX1 impairs ECM-integrin-FA signaling, cell migration, and focal adhesions in vivo and in cultured cells; this function is non-cell autonomous in embryos; interfering with the ECM-integrin-FA axis during the Tbx1-required time window (E8.5-E9.5) causes outflow tract dysmorphogenesis. |
Mouse embryo analysis, cultured cell loss-of-function, mosaic analysis, integrin/FA signaling assays |
Human molecular genetics |
High |
31180501
|
| 2019 |
TBX1 functions as a tumor suppressor in thyroid cancer cells by inhibiting PI3K/AKT and MAPK/ERK pathways; ectopic TBX1 expression inhibits AKT phosphorylation at Ser473 and ERK phosphorylation via downstream targets RNF41, PARK2, and PHLPP2; TBX1 promoter is frequently methylated in thyroid cancer. |
ChIP-sequencing, dual-luciferase reporter assays, ectopic expression and knockdown in thyroid cancer cells, in vitro and in vivo (nude mouse) functional assays |
Thyroid |
Medium |
30543152
|
| 2021 |
Single-cell RNA-sequencing identifies a Tbx1-marked multilineage primed (MLP) progenitor population within cardiopharyngeal mesoderm with bipotent cardiac and branchiomeric muscle properties; Tbx1 regulates maturation of MLP cells while restricting ectopic non-mesodermal gene expression; TBX1 acts partly through altering chromatin accessibility of enriched genes in MLP cells. |
Single-cell RNA-sequencing, ATAC-seq (chromatin accessibility), genetic tracing in mouse |
Nature communications |
High |
34789765
|
| 2023 |
Single-cell RNA-sequencing of Tbx1 null and control mouse embryos reveals three dynamic transitions of pharyngeal NCCs through differentiated CNCCs; loss of Tbx1 non-autonomously disrupts these transitions by altering mesoderm-to-CNCC cell-cell communication, upregulating/prematurely activating BMP signaling, reducing MAPK signaling, and disrupting aortic arch artery formation and cardiac outflow tract septation. |
Single-cell RNA-sequencing of Tbx1 null and control pharyngeal apparatus + heart tissues, cell-cell communication analysis |
Nature communications |
High |
36941249
|
| 2023 |
TBX1 in lymphatic endothelial cells drives an immunosuppressive program post-myocardial infarction; Tbx1-activated LECs penetrate the infarcted area and promote tolerogenic dendritic cells and regulatory T cells through Ccl21 and Icam1, thereby suppressing autoreactive CD8+ T cells and facilitating post-MI repair. |
Conditional Tbx1 knockout in LECs, scRNA-seq, immunofluorescence, cell transfer experiments, post-MI mouse models |
Immunity |
High |
37625409
|